SymBio Pharmaceuticals Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-4,637	-3,806	-1,195	2,106	2,032	-4,090	Upgrade
Depreciation & Amortization	-	-	98	99	93.96	63.84	Upgrade
Other Amortization	-	-	-	-	1.95	27.02	Upgrade
Loss (Gain) From Sale of Assets	100	131	568	-	0.69	0.04	Upgrade
Stock-Based Compensation	-	-	-	-	124.27	102.38	Upgrade
Other Operating Activities	-13	27	-377	-420	-1,048	-30.82	Upgrade
Change in Accounts Receivable	258	489	1,171	62	-1,741	142.29	Upgrade
Change in Inventory	-125	54	237	-82	559.24	-944.44	Upgrade
Change in Accounts Payable	-295	-215	-356	662	-595.78	578.36	Upgrade
Change in Other Net Operating Assets	-80	-96	-340	-813	711.88	29.08	Upgrade
Operating Cash Flow	-4,792	-3,416	-194	1,614	140.04	-4,122	Upgrade
Operating Cash Flow Growth	-	-	-	1052.51%	-	-	Upgrade
Capital Expenditures	-10	-19	-204	-2	-25.45	-15.67	Upgrade
Sale (Purchase) of Intangibles	-18	-27	-28	-45	-38.38	-133.26	Upgrade
Other Investing Activities	7	43	-144	-	-7.01	-11.38	Upgrade
Investing Cash Flow	-21	-3	-376	-47	-70.85	-160.31	Upgrade
Total Debt Issued	1,707	-	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	1,707	-	-	-	-	-	Upgrade
Issuance of Common Stock	-	709	681	630	0.9	4,256	Upgrade
Repurchase of Common Stock	-17	-	-	-2	-68.83	-6.39	Upgrade
Other Financing Activities	-2	-1	-1	-1	-4	-27.29	Upgrade
Financing Cash Flow	1,688	708	680	627	-71.92	4,222	Upgrade
Foreign Exchange Rate Adjustments	-179	158	125	213	14.21	-1.5	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-1	14	-	-0	Upgrade
Net Cash Flow	-3,304	-2,553	234	2,421	11.48	-62.2	Upgrade
Free Cash Flow	-4,802	-3,435	-398	1,612	114.59	-4,138	Upgrade
Free Cash Flow Growth	-	-	-	1306.78%	-	-	Upgrade
Free Cash Flow Margin	-264.72%	-140.09%	-7.12%	16.11%	1.39%	-138.54%	Upgrade
Free Cash Flow Per Share	-102.34	-76.17	-9.97	40.70	2.95	-125.59	Upgrade
Cash Interest Paid	16	-	-	-	-	-	Upgrade
Cash Income Tax Paid	17	-39	354	363	3.8	1.9	Upgrade
Levered Free Cash Flow	-3,315	-2,055	-143.5	1,542	-226.95	-3,019	Upgrade
Unlevered Free Cash Flow	-3,247	-2,055	-143.5	1,542	-226.95	-3,019	Upgrade
Change in Working Capital	-242	232	712	-171	-1,065	-194.72	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.